发明名称 Compositions comprising the prodrug pentaerythritolyl-4-arm-(peg-1-methylene-2-oxo-vinylamino acetate linked-irinotecan)-20k for use for achieving sustained therapeutic drug concentrations in a subject
摘要 <p>Among other things, a method of treating a human having brain cancer is, the method comprising administering via a non-continuous dosing regimen to the human having brain cancer, a therapeutically effective amount of a pharmaceutical composition comprising a prodrug or a pharmaceutically acceptable salt thereof, wherein the non-continuous dosing regimen comprises administering the pharmaceutical composition no more frequently than once every seven days for at least two dosings.</p>
申请公布号 IL211888(A) 申请公布日期 2015.08.31
申请号 IL20110211888 申请日期 2011.03.23
申请人 NEKTAR THERAPEUTICS 发明人
分类号 A61K;A61P;C07D 主分类号 A61K
代理机构 代理人
主权项
地址